Persephone Biosciences
Drug DiscoveryWebsite
Persephone Biosciences valuation and funding history | Last updated: May 1, 2025 | 3 funding rounds
Current Valuation
N/A
As of May 1, 2025
Total Funding Raised
$21.6M
Across 3 rounds
Last Round
Later Stage VC
Amount undisclosed
Last Funding
May 2025
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| N/A | Unknown | Undisclosed | N/A | - |
| January 8, 2018 | Accelerator/Incubator | $120.0K | N/A | - |
| July 17, 2017 | Accelerator/Incubator | Undisclosed | N/A | - |
Valuation Analysis
Current Valuation Metrics
Persephone Biosciences is currently valued at N/A as of May 1, 2025. The company has raised a total of $21.6M in funding across 3 funding rounds.
Explore More Data
Detailed analysis for Persephone Biosciences
What is Persephone Biosciences Worth in 2026?
Persephone Biosciences is a leading private company in the Drug Discovery sector. Track Persephone Biosciences's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Persephone Biosciences Valuation is Determined
Private company valuations like Persephone Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.